Literature DB >> 23666797

Merlin, the NF2 gene product.

Nives Pećina-Šlaus1.   

Abstract

Merlin, the protein product of NF2 gene, is one of the most versatile tumor suppressors capable of integrating different mechanisms that regulate cell proliferation, motility, survival and signaling pathways underlying and governing those mechanisms. Merlin is considered a member of the band 4.1 families of cytoskeleton-associated proteins also called ERM family and acts as tumor suppressor. The main cause for transformation of Schwann cells into schwannomas is credited to the inactivation of the neurofibromin 2 (NF2) gene and the consecutive loss of its protein merlin. Recent scientific advances improved our understanding of pathogenic mechanisms involving NF2 gene. The present review brings genetic properties of NF2 gene, molecular characteristics of merlin, summarizes mutational spectra and explains merlin's multifunctional roles regarding its involvement in neurofibromatosis associated tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23666797     DOI: 10.1007/s12253-013-9644-y

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  64 in total

1.  Analysis of the human neurofibromatosis type 2 gene promoter and its expression.

Authors:  D B Welling; E M Akhmametyeva; R L Daniels; J M Lasak; L Zhu; B A Miles-Markley; L S Chang
Journal:  Otolaryngol Head Neck Surg       Date:  2000-10       Impact factor: 3.497

Review 2.  Merlin, a multi-suppressor from cell membrane to the nucleus.

Authors:  Lu Zhou; C Oliver Hanemann
Journal:  FEBS Lett       Date:  2012-03-21       Impact factor: 4.124

Review 3.  Molecular genetics of meningiomas.

Authors:  Brian T Ragel; Randy L Jensen
Journal:  Neurosurg Focus       Date:  2005-11-15       Impact factor: 4.047

4.  Analysis of cytogenetic aberrations in sporadic vestibular schwannoma by comparative genomic hybridization.

Authors:  Dimitrios Koutsimpelas; Uwe Felmeden; Wolf J Mann; Jürgen Brieger
Journal:  J Neurooncol       Date:  2010-09-26       Impact factor: 4.130

5.  Defects in neurofibromatosis 2 protein function can arise at multiple levels.

Authors:  D H Gutmann; R T Geist; H m Xu; J S Kim; S Saporito-Irwin
Journal:  Hum Mol Genet       Date:  1998-03       Impact factor: 6.150

6.  Tumour and tumour-like conditions of peripheral nerve origin: ten years' experience.

Authors:  A Ghosh; O P Talwar; S V Pradhan
Journal:  Kathmandu Univ Med J (KUMJ)       Date:  2010 Jan-Mar

7.  Conditional biallelic Nf2 mutation in the mouse promotes manifestations of human neurofibromatosis type 2.

Authors:  M Giovannini; E Robanus-Maandag; M van der Valk; M Niwa-Kawakita; V Abramowski; L Goutebroze; J M Woodruff; A Berns; G Thomas
Journal:  Genes Dev       Date:  2000-07-01       Impact factor: 11.361

Review 8.  The merlin interacting proteins reveal multiple targets for NF2 therapy.

Authors:  Daniel R Scoles
Journal:  Biochim Biophys Acta       Date:  2007-10-12

9.  Identification of recurrent regions of chromosome loss and gain in vestibular schwannomas using comparative genomic hybridisation.

Authors:  C Warren; L A James; R T Ramsden; A Wallace; M E Baser; J M Varley; D G Evans
Journal:  J Med Genet       Date:  2003-11       Impact factor: 6.318

10.  Frequency of loss of heterozygosity of the NF2 gene in schwannomas from Croatian patients.

Authors:  Nives Pećina-Slaus; Martina Zeljko; Hrvoje Ivan Pećina; Tamara Nikuseva Martić; Niko Bacić; Davor Tomas; Reno Hrasćan
Journal:  Croat Med J       Date:  2012-08       Impact factor: 1.351

View more
  16 in total

1.  Merlin/NF2 Suppresses Pancreatic Tumor Growth and Metastasis by Attenuating the FOXM1-Mediated Wnt/β-Catenin Signaling.

Authors:  Ming Quan; Jiujie Cui; Tian Xia; Zhiliang Jia; Dacheng Xie; Daoyan Wei; Suyun Huang; Qian Huang; Shaojiang Zheng; Keping Xie
Journal:  Cancer Res       Date:  2015-10-19       Impact factor: 12.701

2.  Epithelial-specific isoforms of protein 4.1R promote adherens junction assembly in maturing epithelia.

Authors:  Shu-Ching Huang; Jia Y Liang; Long V Vu; Faye H Yu; Alexander C Ou; Jennie Park Ou; Henry S Zhang; Kimberly M Burnett; Edward J Benz
Journal:  J Biol Chem       Date:  2019-11-27       Impact factor: 5.157

3.  Protein 4.1R Influences Myogenin Protein Stability and Skeletal Muscle Differentiation.

Authors:  Shu-Ching Huang; Anyu Zhou; Dan T Nguyen; Henry S Zhang; Edward J Benz
Journal:  J Biol Chem       Date:  2016-10-25       Impact factor: 5.157

4.  Loss of p53 expression is accompanied by upregulation of beta-catenin in meningiomas: a concomitant reciprocal expression.

Authors:  Nives Pećina-Šlaus; Anja Kafka; Tomislav Vladušić; Davor Tomas; Monika Logara; Josip Skoko; Reno Hrašćan
Journal:  Int J Exp Pathol       Date:  2016-06-12       Impact factor: 1.925

Review 5.  Genetic/molecular alterations of meningiomas and the signaling pathways targeted.

Authors:  Patrícia Domingues; María González-Tablas; Álvaro Otero; Daniel Pascual; Laura Ruiz; David Miranda; Pablo Sousa; Jesús María Gonçalves; María Celeste Lopes; Alberto Orfao; María Dolores Tabernero
Journal:  Oncotarget       Date:  2015-05-10

6.  Oncogenic role of Merlin/NF2 in glioblastoma.

Authors:  P A Guerrero; W Yin; L Camacho; D Marchetti
Journal:  Oncogene       Date:  2014-07-21       Impact factor: 9.867

7.  Tumor suppressor Nf2/merlin drives Schwann cell changes following electromagnetic field exposure through Hippo-dependent mechanisms.

Authors:  A Colciago; S Melfi; G Giannotti; V Bonalume; M Ballabio; L Caffino; F Fumagalli; V Magnaghi
Journal:  Cell Death Discov       Date:  2015-09-07

8.  A splicing variant of Merlin promotes metastasis in hepatocellular carcinoma.

Authors:  Zai-Li Luo; Shu-Qun Cheng; Jie Shi; Hui-Lu Zhang; Cun-Zhen Zhang; Hai-Yang Chen; Bi-Jun Qiu; Liang Tang; Cong-Li Hu; Hong-Yang Wang; Zhong Li
Journal:  Nat Commun       Date:  2015-10-07       Impact factor: 14.919

Review 9.  Molecular Genetics of Intracranial Meningiomas with Emphasis on Canonical Wnt Signalling.

Authors:  Nives Pećina-Šlaus; Anja Kafka; Mirna Lechpammer
Journal:  Cancers (Basel)       Date:  2016-07-15       Impact factor: 6.639

10.  Hippo transducer TAZ promotes epithelial mesenchymal transition and supports pancreatic cancer progression.

Authors:  Dacheng Xie; Jiujie Cui; Tian Xia; Zhiliang Jia; Liang Wang; Wenfei Wei; Anna Zhu; Yong Gao; Keping Xie; Ming Quan
Journal:  Oncotarget       Date:  2015-11-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.